DRUGS. The Procter & Gamble Company recently signed Squire Patton Boggs to lobby on behalf of the consumer goods company in connection with the Over-the-Counter Monograph Safety, Innovation and Reform Act, according to disclosures. The bill would amend the Federal Food, Drug, and Cosmetic Act to clarify the regulatory framework for certain nonprescription drugs that are marketed without an approved new drug application. David Schnittger, former deputy chief of staff to ex-Speaker John Boehner (R-Ohio), and David Stewart, former staff director for the House Ways and Means Committee, will work on the account.
REAL ESTATE. A10 Associates recently signed three new clients, which are all Massachusetts-based firms, to focus on real estate and land use issues. Construction engineering consulting firm CDR Maguire Inc. hired the firm to work on legislative and regulatory issues affecting the real estate and construction industries; real estate development, management, and consulting firm the Drew Company hired the firm to work on legislative and regulatory issues affecting the real estate industry; and construction services company J. Derenzo Companies hired the firm to work on legislative and regulatory issues affecting the construction industry.
Jessica Tocco, former assistant to former Commerce Secretary Carlos Gutierrez, will work on all the accounts, according to disclosures.
DRUGS. Exelixis Inc., an oncology-focused biotechnology company based in California, recently signed Arnold & Porter Kaye Scholer to work on issues related to access, coverage and payment for cancer drugs. Eugenia Pierson, who worked for the House Energy and Commerce Committee, and Kristine Blackwood, who worked for the Department of Health and Human Services, among others, will work on the account.